Ondansetron Injection
Product Images NDC 68083-113

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 68083-113). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gland Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ondansetron Spl Label

This is a description of Ondansetron Injection USP, manufactured by Gland Pharma Limited in Hyderabad, India. The injection contains 4mg of Ondansetron in 2mL of solution, with a concentration of 2 mg/mL. The product is intended for intravenous or intramuscular injection and is packaged with a barcode for identification. The expiration date of the product is included, but the lot number is not provided.*

FDA Label Image

Ondansetron Spl Structure

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.